Acadia Pharmaceuticals
ACAD
ACAD
199 hedge funds and large institutions have $3.7B invested in Acadia Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 71 increasing their positions, 60 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
18% more repeat investments, than reductions
Existing positions increased: 71 | Existing positions reduced: 60
7% more funds holding
Funds holding: 186 → 199 (+13)
1.38% less ownership
Funds ownership: 97.22% → 95.84% (-1.4%)
Holders
199
Holding in Top 10
4
Calls
$33M
Puts
$27.8M
Top Buyers
| 1 | +$35.6M | |
| 2 | +$34.7M | |
| 3 | +$23.6M | |
| 4 |
GTC
Ghost Tree Capital
New York
|
+$20.8M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$19.3M |
Top Sellers
| 1 | -$50.8M | |
| 2 | -$49.8M | |
| 3 | -$28.5M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$20.2M |
| 5 |
Citigroup
New York
|
-$17.9M |